Sort by
Keyphrases
Secondary Prevention
100%
Ischemic Heart Disease
100%
Fixed-dose Combination
100%
Risk Factors
50%
Cardiovascular Disease
50%
Beneficial Effects
50%
Developing Countries
50%
Access to Treatment
50%
Diabetes
25%
High Cost
25%
Clinical Trials
25%
High Risk
25%
Acute Myocardial Infarction
25%
Drug Combination
25%
Aspirin
25%
Therapeutic Strategies
25%
Treatment Effect
25%
Myocardial Infarction Patients
25%
Treatment Discontinuation
25%
Statins
25%
Prevention Programs
25%
Heart Stroke
25%
Low-middle Income Countries
25%
New Therapeutic Approaches
25%
Drug Regimen
25%
Cardiovascular Events
25%
Angiotensin-converting Enzyme Inhibitor (ACEi)
25%
Cardiovascular Prevention
25%
Leading Causes of Death
25%
Health Resources
25%
Treatment Costs
25%
Polypill
25%
Coronary Events
25%
Actual Effect
25%
Combination Drug Therapy
25%
Revention
25%
Contrast Combination
25%
Pharmacology, Toxicology and Pharmaceutical Science
Ischemic Heart Disease
100%
Cardiovascular Disease
75%
Cerebrovascular Accident
50%
Pharmacotherapy
25%
Heart Infarction
25%
Combination Drug
25%
Acetylsalicylic Acid
25%
Clinical Trial
25%
Recurrent Disease
25%
Statin (Protein)
25%
Acute Heart Infarction
25%
Dipeptidyl Carboxypeptidase Inhibitor
25%
Aves
25%